Low-grade B Cell Non-Hodgkin's Lymphoma

Also known as: Lymphoma, Non-Hodgkin Lymphoma, B-Cell / B Cell Non-Hodgkin's Lymphoma / B-cell Non-Hodgkin's Lymphomas / B-Cell Non-Hodgkin Lymphoma / B-Cell Non-Hodgkin Lymphomas(NHL) / B-cell Non Hodgkin Lymphoma (NHL) / Lymphomas non-Hodgkin's B-cell / Non-hodgkin Lymphoma,B Cell / Non-Hodgkin's B-cell Lymphoma / B-cell Non-Hodgkins Lymphoma / B-Cell NHL / Non-Hodgkin Lymphoma, B-cell / B-Cell Non-Hodgkin Lymphoma (NHL) / Lymphoma, B-Cell, Non-Hodgkin's Lymphoma / B-cell Non Hodgkin's Lymphoma / B-Cell Non-Hodgkin's Lymphoma / B-cell Non Hodgkin Lymphoma / B cell non-hodgkin lymphoma / B Cell NHL / B-cell lymphoma NOS / B-cell lymphoma (disorder) / Non-Hodgkin lymphoma, no ICD-O subtype (morphologic abnormality) / B-cell neoplasm (morphologic abnormality) / B-cell lymphoma / Lymphoma, B-Cell

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00073Rituximab2Completed1